Our Leadership and Senior Management

The CEO, CFO, and executive management staff of Finger Lakes Community Health are all seasoned healthcare professionals with years of experience, many of which have been spent at our health centers. If you have questions for our team, please contact them using their email addresses here.

Mary Zelazny

Chief Executive Officer

maryz@flchealth.org

Anne Slack

Chief Financial Officer

annes@flchealth.org

Lawreen Duel

Chief Compliance Officer

lawreen@flchealth.org

Jose Canario, MD

Chief Medical Officer

josec@flchealth.org

Anthony Mendicino, DDS

Chief Dental Officer

tonym@flchealth.org

Ellen Hey

Chief Quality Officer

ellenh@flchealth.org

Sirene Garcia

Chief Innovation Officer

sirene@flchealth.org

Yissette Rivas

Chief Service Officer

yrivas@flchealth.org

Jill Rapp

Director of Human Resources

jillr@flchealth.org

Amanda Felice

Director of Behavioral Health

afelice@flchealth.org

Kathleen Dorety

Executive Assistant to CEO

kathleend@flchealth.org

Refuerzo:

Si recibió la serie de vacunas Moderna:

Puede recibir una dosis de refuerzo de Janssen (Johnson & Johnson) o Pfizer 5 meses después de su segunda dosis o dosis adicional.

Si recibió la serie de vacunas de Pfizer:

Puede recibir una dosis de refuerzo de Janssen (Johnson & Johnson) o Pfizer 5 meses después de su segunda dosis o dosis adicional.
El refuerzo de Pfizer solo está disponible para personas mayores de 12 años.

Si recibió la vacuna Janssen (Johnson & Johnson):

Puede recibir una dosis de refuerzo de Janssen (Johnson & Johnson) o Pfizer 2 meses después de la vacunación.
El refuerzo de Janssen (Johnson & Johnson) solo está disponible para personas mayores de 18 años.

BOOSTER Shot:

If you received the Moderna vaccine series:

You can receive a booster dose of Janssen (Johnson & Johnson) or Pfizer 5 months after your second dose or additional dose.

If you received the Pfizer vaccine series:

You can receive a booster dose of Janssen (Johnson & Johnson) or Pfizer 5 months after your second dose or additional dose.
The Pfizer booster is only available for people who are 12 years of age and older.

If you received the Janssen (Johnson & Johnson) vaccination:

You can receive a booster dose of Janssen (Johnson & Johnson) or Pfizer 2 months after your vaccination.
The Janssen (Johnson & Johnson) booster is only available for people who are 18 years of age and older.

Si recibió la serie de vacunas de Pfizer:

• Puede recibir una dosis de refuerzo de Moderna, Janssen (Johnson & Johnson) o Pfizer 5 meses después de su segunda dosis o dosis adicional.
• El refuerzo de Pfizer solo está disponible para personas mayores de 12 años.

Si recibió la vacuna Janssen (Johnson & Johnson):
• Puede recibir una dosis de refuerzo de Moderna, Janssen (Johnson & Johnson) o Pfizer 2 meses después de la vacunación.
• El refuerzo de Janssen (Johnson & Johnson) solo está disponible para personas mayores de 18 años.

Pfizer (12-17) Additional Dose Qualifiers

Active cancer treatment for tumors or cancers of the blood
Organ transplant recipients who are taking medicine to suppress the immune system
Stem cell transplant recipients (within the last 2 years or taking immunosuppressive medications)
Moderate or severe primary immunodeficiency (such as DiGeorge syndrome, Wiskott-Aldrich syndrome)
Advanced or untreated HIV infection

Si recibió la vacuna Janssen (Johnson & Johnson):

• Puede recibir una dosis de refuerzo de Moderna, Janssen (Johnson & Johnson) o Pfizer 2 meses después de la vacunación.
• El refuerzo de Janssen (Johnson & Johnson) solo está disponible para personas mayores de 18 años.

Si recibió la serie de vacunas Moderna:

Puede recibir una dosis de refuerzo de Moderna, Janssen (Johnson & Johnson) o Pfizer 5 meses después de su segunda dosis o dosis adicional.
El refuerzo Moderna solo está disponible para personas mayores de 18 años.

Calificadores de dosis adicionales

Los estudios mostraron respuestas inmunitarias inadecuadas a solo dos dosis en personas con las siguientes condiciones:

Tratamiento oncológico activo para tumores o cánceres de la sangre
Receptores de trasplantes de órganos que toman medicamentos para inhibir el sistema inmunitario
Receptores de trasplantes de células madre (en los últimos 2 años o tomando medicamentos inmunosupresores)
Inmunodeficiencia primaria moderada o grave (como el síndrome de DiGeorge, el síndrome de Wiskott-Aldrich)
Infección avanzada o no tratada de VIH
Tratamiento activo con dosis altas de cortico-esteroides (p. ej., cortisona, prednisona) u otros medicamentos que pueden suprimir su respuesta inmunitaria.
Si tiene alguna pregunta sobre si debe recibir una dosis adicional, comuníquese con su proveedor de atención médica.

NOTA: Si no ha completado su serie de dos dosis, su dosis adicional se puede programar al recibir su segunda vacunación.

Qualifying Medical Condition

Cancer (current or in remission, including 9/11-related cancers);
Chronic kidney disease;
Pulmonary Disease, limited to, COPD (chronic obstructive pulmonary disease), asthma (moderate-to-severe), pulmonary fibrosis, cystic fibrosis, tuberculosis, and 9/11 related pulmonary diseases;
Intellectual and Developmental Disabilities including Down
Syndrome;
Heart conditions, including but not limited to heart failure, coronary artery disease, cardiomyopathies, or hypertension (high blood pressure);
Immunocompromised state (weakened immune system) including but not limited to solid organ transplant or from blood or bone marrow transplant, immune deficiencies, HIV, use of corticosteroids, use of other immune weakening medicines, or other causes;
Severe Obesity (BMI 40 kg/m2 or higher), Obesity (body mass index [BMI] of 30 kg/m2 or higher but < 40 kg/m2), Overweight (BMI of 25 kg/m2 or higher but < 30kg/m2);
Pregnant or recently pregnant;
Sickle cell disease or Thalassemia;
Type 1 or 2 diabetes mellitus;
Cerebrovascular disease (affects blood vessels and blood supply to the brain);
Neurologic conditions include but not limited to Alzheimer's
Disease or dementia;
Liver disease limited to cirrhosis, non-alcoholic fatty liver disease, alcoholic liver disease, or autoimmune hepatitis;
Current or former smoker;
Substance use disorder,
Mental health disorders are limited to mood disorders including depression, schizophrenia spectrum disorders.

Qualifying Medical Condition

Cancer (current or in remission, including 9/11-related cancers);
Chronic kidney disease;
Pulmonary Disease, limited to, COPD (chronic obstructive pulmonary disease), asthma (moderate-to-severe), pulmonary fibrosis, cystic fibrosis, tuberculosis, and 9/11 related pulmonary diseases;
Intellectual and Developmental Disabilities including Down
Syndrome;
Heart conditions, including but not limited to heart failure, coronary artery disease, cardiomyopathies, or hypertension (high blood pressure);
Immunocompromised state (weakened immune system) including but not limited to solid organ transplant or from blood or bone marrow transplant, immune deficiencies, HIV, use of corticosteroids, use of other immune weakening medicines, or other causes;
Severe Obesity (BMI 40 kg/m2 or higher), Obesity (body mass index [BMI] of 30 kg/m2 or higher but < 40 kg/m2), Overweight (BMI of 25 kg/m2 or higher but < 30kg/m2);
Pregnant or recently pregnant;
Sickle cell disease or Thalassemia;
Type 1 or 2 diabetes mellitus;
Cerebrovascular disease (affects blood vessels and blood supply to the brain);
Neurologic conditions include but not limited to Alzheimer's
Disease or dementia;
Liver disease limited to cirrhosis, non-alcoholic fatty liver disease, alcoholic liver disease, or autoimmune hepatitis;
Current or former smoker;
Substance use disorder,
Mental health disorders are limited to mood disorders including depression, schizophrenia spectrum disorders.

Additional Dose Qualifiers

Studies showed inadequate immune responses to only two doses in people with the following conditions:

Active cancer treatment for tumors or cancers of the blood
Organ transplant recipients who are taking medicine to suppress the immune system
Stem cell transplant recipients (within the last 2 years or taking immunosuppressive medications)
Moderate or severe primary immunodeficiency (such as DiGeorge syndrome, Wiskott-Aldrich syndrome)
Advanced or untreated HIV infection
Active treatment with high-dose corticosteroids (e.g. cortisone, prednisone) or other drugs that may suppress your immune response.
If you have a question about whether you should receive an additional dose, please contact your health care provider.

NOTE: If you have not completed your two-dose series, your additional dose can be scheduled at the completion of your second vaccination.